Earnings Labs

Nortech Systems Incorporated (NSYS)

Q2 2017 Earnings Call· Thu, Aug 10, 2017

$13.80

-3.16%

Key Takeaways · AI generated
AI summary not yet generated for this transcript. Generation in progress for older transcripts; check back soon, or browse the full transcript below.

Same-Day

-0.00%

1 Week

-3.12%

1 Month

+0.23%

vs S&P

-2.35%

Transcript

Operator

Operator

Good day, ladies and gentlemen, and welcome to the Nortech Systems' Second Quarter 2017 Earnings Conference Call. All lines have been placed on a listen-only mode. And the floor will be open for questions and comments, following the presentation. [Operator Instructions] At this time, it is my pleasure to turn the floor over to your host, Paula Graff, CFO of Nortech Systems. Ma'am, the floor is yours.

Paula Graff

Analyst

Thank you. Good morning and welcome to Nortech Systems second quarter 2017 conference call. I'm Paula Graff, Vice President and CFO; and with me, is Rich Wasielewski, Nortech's President and CEO. Following my introduction, Rich will offer some comments on our second quarter results, our markets and our strategic initiatives, then we will open up the call to your questions. Before we begin, please be advised that statements made during this call may be forward-looking and are subject to risk factors and uncertainties. Please see the Safe Harbor statements in our press release and our SEC filings. Now, I will turn the call over to Rich Wasielewski. Rich?

Richard Wasielewski

Analyst

Thanks Paula, and good morning, everyone. We're pleased to report continued progress on our two main strategic initiatives of growing our medical market and strengthening our global capabilities. In the quarter, we also added two critical pieces in helping us meet our long-term objectives. We signed a new banking agreement with Bank of America and appointed a COO to oversee our growing global operations. I'll expand on both later in the call. But first, I look at the second quarter results. Yesterday, we reported net sales of $30.1 million for the second quarter ended June 30th, up 4% over the prior year, and up 6% sequentially from the first quarter. Our 90-day backlog end of the second quarter up 4% year-over-year. Our revenue growth is in line with industrial global trends, and we continue to see mixed results by markets and segments within markets. Looking at our core markets, our medical sales grew in the quarter. They were up 14% over the prior year period and comprised almost half of our total revenue at 48%. Last year, it was 44%. Our 30-day medical backlog increased 7% from the prior year period and 3% from the first quarter. Our sales of defense and aerospace customers were $3.9 million in the quarter, up 16% sequentially, but down 11% to prior year. Our 90-day defense backlog showed similar trends with the second quarter, up 3% sequentially, but down 11% year-over-year. Our defense customers continue to show mixed results. Although we're seeing increased activity in quoting and booking, the size of contracts and the timing remain contingent on budget constraints. Finally, our industrial sales were flat year-over-year for the second quarter, although up 7% sequentially from Q1. We saw some seasonality in the results across the segment, but our diverse customer base remains a…

Operator

Operator

Thank you. The floor is now open for questions. [Operator Instructions] Okay we have a question that came in from Sheldon Grodsky. Please state your question.

Sheldon Grodsky

Analyst

Hi. Actually, I have two. I apologize, I got a little -- I was having some distractions here. So, I didn't catch everything. Did you say that you had a bad debt recovery in the second quarter?

Richard Wasielewski

Analyst

Yes, we had a bad debt loss in the third quarter of last year with a medical startup company. And we made that -- they came out of bankruptcy with a plan and paid us off less the -- about a third of the cost -- about 25% of the cost for legal fees to get through it. So, yes, we had that bad debt that was in the third quarter of last year, now became a good guy here in the second quarter.

Sheldon Grodsky

Analyst

Well, congratulations on that. And did you indicate something about strength in the second half of this year?

Richard Wasielewski

Analyst

Well, again, the comment was our medical and global operations have been strong compared to last year. They continue -- they'll continue in the second half from what we can tell. The industrial business is mixed. Some of our -- the transportation segment is really getting hurt, and that carried a lot of weight in our industrial accounts about 20% to 25%. The defense accounts, although are steady, they're not growing and we're still seeing small orders. It seems like the defense budget is still up in the air, for us, at least on the defense side and the vehicle side, which is where we participate a lot. We're trying to make a pivot to more aerospace and more communications cable -- custom cables.

Sheldon Grodsky

Analyst

Thank you.

Richard Wasielewski

Analyst

Thanks Sheldon. I forgot to say good morning to you.

Sheldon Grodsky

Analyst

Good morning.

Operator

Operator

[Operator Instructions] Okay, our next question comes from Michael Hughes [ph]. Please state your question.

Unidentified Analyst

Analyst

Hi Rich. Just was wondering what type of acquisitions you'd be looking at with your new line of credit?

Richard Wasielewski

Analyst

Good morning Mike. It's a little changed. It's a little changed than in the past where we bought distressed and stressed companies and it takes a lot of effort to get those going. That's what we're excited about with this expanded line and Bank of America's willingness to grow with us with maybe not the typical borrowing base. It's important for us to prove to them that that we're strong on our equity side, but to get on that side. So, that requires a much different funding than in the past. There might be some goodwill involved because you're buying a little bit of technology. You're buying more, what I call, going Jennie business as opposed to the distress business. So, those are going to come out with higher multiples. And possibly some goodwill with it. So, it's going to take a lot of analytics and it's going to take a lot of confidence on the return and the analysis to get Bank of America to play with us. So, there isn't -- if I said specifically anything that complements the medical markets, we're playing very well with engineering. We're playing very well with the contract, the PC board and also the cable bills. But we are still purchasing plastics and the boxes and that would be one area that in the medical area that we'd be looking for. So, I would think that -- and any time you can get talent in our business nowadays. It's all about the people and the talents. So, we'd be looking at more engineering support, more technical support wherever we can.

Unidentified Analyst

Analyst

Okay, great. Thanks.

Richard Wasielewski

Analyst

You bet. Thank you for the question.

Operator

Operator

[Operator Instructions]

Richard Wasielewski

Analyst

Well, if there are no further questions, we'll conclude this call. Thank you for your interest in Nortech and we look forward to updating you in the future. Have a great day everyone.